Figure 2.

The effect of girinimbine on HUVECs’ migratory ability was determined by scratch-wound healing assay.

Notes: (A) Invaded areas in control and girinimbine-treated (2.5, 5, 10 μg/mL) after 24 h. (B) Quantification of the number of migrated cells after 6, 12, and 24 h exposure to indicated concentrations of girinimbine. Data are shown as percent of cell migration compared to 0 h control. Statistical significance is expressed as **P<0.01, *P<0.05 versus control.

Abbreviations: HUVECs, human umbilical vein endothelial cells; h, hour(s).